House Approves Blumenauer’s Medical Marijuana Research Act

Legislation removes barriers to much-needed research on health benefits of marijuana.

DISTRICT OF COLUMBIA:Today (12/9/2020), the U.S. House of Representatives approved the Medical Marijuana Research Act, bipartisan legislation introduced by U.S. Reps. Earl Blumenauer (D-OR) and Andy Harris (R-MD) to address burdensome impediments to legitimate medical research.

Although 99 percent of Americans now live in a state with some form of legalized marijuana, current federal law greatly limits researchers’ ability to study the health benefits of cannabis. Current barriers include the overly burdensome registration process, redundant protocol reviews, lack of adequate research material, and unnecessarily onerous security requirements.

“The cannabis laws in this country are broken, especially those that deal with research. It’s illegal everywhere in America to drive under the influence of alcohol, cannabis, or any other substance. But we do not have a good test for impairment because we can’t study it … This is insane and we need to change it,” Blumenauer said today on the House floor. “At a time when there are four million registered medical cannabis patients, and many more likely self-medicate, when there are 91 percent of Americans supporting medical cannabis, it’s time to change the system. Our bill will do precisely that.”

While the United States leads the world in biomedical research, research on cannabis lags far behind. A 2017 National Academies of Sciences, Engineering, and Medicine report found that “research on the health effects of cannabis and cannabinoids has been limited in the United States, leaving patients, health care professionals, and policy makers without the evidence they need to make sound decisions regarding the use of cannabis and cannabinoids.”

The Medical Marijuana Research Act will address these limitations by:

  • Providing a pathway for researchers to study the cannabis products consumers are using from state-legal programs.
  • Streamlining the burdensome and often duplicative license process for researchers seeking to conduct marijuana research, while still maintaining all necessary safeguards against misuse and abuse.
  • Addressing the woefully inadequate, both in quantity and quality, supply of medical-grade marijuana available for use in such research.
  • Requiring a report by the secretary of the U.S. Department of Health and Human Services on the status and results of new research on marijuana benefits.

This was the second vote held by the U.S. House of Representatives in the past week on Blumenauer’s federal cannabis reform priorities, following the passage of the Marijuana Opportunity Reinvestment and Expungement (MORE) Act on Friday, December 4.

The full text of the Medical Marijuana Research Act can be found here.

Congressman Blumenauer Reacts To New Report Detailing Vast Economic Benefits To MORE Act

CBO projections show that cannabis reform will lead to huge growth in revenue, cuts to federal prison spending, and more.

DISTRICT OF COLUMBIA: Following a historic vote in the U.S. House of Representatives to end the federal prohibition on cannabis last week, the non-partisan Congressional Budget Office, or CBO, released a new report today detailing vast economic benefits to the legislation.

Among other things, the agency found that the Marijuana Opportunity Reinvestment and Expungement (MORE) Act would increase revenues by about $13.7 billion, cut federal prison spending by $1 billion, and reduce time served in federal prison among existing and future inmates by 73,000 person-years.

U.S. Rep. Blumenauer (D-OR), co-chair of the Congressional Cannabis Caucus and a key sponsor of the MORE Act, lauded these findings today on the House floor.

“It was sad that my Republican colleagues were unable to understand why we voted to reform our failed prohibition of cannabis. They don’t care about honoring the will of the people and they are unable to grasp the enormity of the racial injustice and damage by selective enforcement against young Black and Brown Americans,” Blumenauer said. “But the CBO score may have some other reasons for them. It shows that the MORE Act would reduce 73,000 person-years of prison time. It would increase revenues by $13.7 billion. It would provide $3 billion for job training and legal aid to people harmed by the war on drugs. While doing all of this, it would reduce the deficit by $7.344 billion.”

If the MORE Act becomes law, the CBO report also estimates that from 2021 – 2030, the U.S. Department of Justice would spend $3 billion from the MORE Act’s Opportunity Trust Fund to provide job training, legal aid, and other services to people harmed by the “War on Drugs.” During this same period, the legislation would lead to $2.7 billion in Small Business Association funding for state and local grants to make loans to cannabis businesses and help governments develop cannabis-licensing rules.

“Even if you don’t care about reducing the damage to Black and Brown Americans, or honoring the will of the people, the economics make it clear,” Blumenauer continued. “Once again, the people are right, and the people deserve strong Congressional support.”

The report released today by the CBO can be found here.

Full text of the MORE Act can be found here.

Chairman Nadler Statement In Support Of H.R. 3884, The Marijuana Opportunity Reinvestment And Expungement (MORE) Act Of 2020

DISTRICT OF COLUMBIA: House Judiciary Committee Chairman Jerrold Nadler (D-NY) issued the following statement in support of H.R. 3884, the Marijuana Opportunity Reinvestment and Expungement (MORE) Act of 2020:

“Mr. Speaker, I am proud to have introduced H.R. 3884, the ‘Marijuana Opportunity Reinvestment and Expungement Act of 2020,’ or the ‘MORE Act of 2020.’

“This long overdue legislation would reverse the failed policy of criminalizing marijuana on the federal level and would take steps to address the heavy toll this policy has taken across the country, particularly on communities of color.

“The MORE Act would make three important changes to federal law:

(1) remove marijuana, or cannabis, from the list of federally controlled substances;

(2) authorize the provision of resources, funded by an excise tax on marijuana, to address the needs of communities that have been seriously impacted by the War on Drugs, including increasing the participation of communities of color in the burgeoning cannabis market; and

(3) provide for the expungement of Federal marijuana convictions and arrests.

“For far too long, we have treated marijuana as a criminal justice problem instead of as a matter of personal choice and public health.  Whatever one’s views are on the use of marijuana for recreational or medicinal use, the policy of arrests, prosecution, and incarceration at the Federal level has proven unwise and unjust.

“This issue is not new to Congress.  There have been many Members who have introduced bills upon which provisions in this bill are based.  For instance, Representative Barbara Lee has sponsored bills that are the foundation of key provisions of the MORE Act, and I thank her for her longstanding leadership on this issue.  Representative Earl Blumenauer has also been an indefatigable advocate and has supported everything we have done to get to where we are today.  I thank him, as well.

“Federal action on this issue would follow the growing recognition in the states that the status quo is unacceptable.  Despite the federal government’s continuing criminalization of marijuana, 36 states and the District of Columbia have legalized medical cannabis.  Fifteen states and the District of Columbia have legalized cannabis for adult recreational use.

“I have long believed that the criminalization of marijuana has been a mistake, and the racially disparate enforcement of marijuana laws has only compounded this mistake, with serious consequences, particularly for communities of color.

“Marijuana is one of the oldest agricultural commodities not grown for food, and it has been used medicinally all over the world since at least 2700 B.C., but its criminalization is a relatively recent phenomenon.

“The use of marijuana, which most likely originated in Asia, later spread to Europe, and made its way to the Americas when the Jamestown settlers brought it with them across the Atlantic.  The cannabis plant has been widely grown in the United States and was used as a component in fabrics during the middle of the 19th century.  During that time period, cannabis was also widely used as a treatment for a multitude of ailments, including muscle spasms, headaches, cramps, asthma, and diabetes.

“It was only in the early part of the 20th century that marijuana began to be criminalized in the United States—mainly because of misinformation and hysteria, based at least in part on racially-biased stereotypes connecting marijuana use and people of color, particularly African-Americans and Latinos.  In 1970, when President Nixon announced the War on Drugs and signed the Controlled Substances Act into law, the federal government placed marijuana on Schedule I, the most restrictive schedule that is attached to the most serious criminal penalties, where—unfairly and unjustifiably—it has remained ever since.

“As a consequence of this decision, thousands of individuals—overwhelmingly people of color—have been subjected, by the federal government, to unjust prison sentences for marijuana offenses.  It is time for this manifest injustice to end.  The MORE Act would remove marijuana from Schedule I and the Controlled Substances Act altogether, thereby decriminalizing it at the Federal level.

“This is only fair, particularly because the same racial animus motivating the enactment of marijuana laws also led to racially disproportionate enforcement of such laws, which has had a substantial, negative impact on communities of color.  In fact, nationwide, the communities that have been most harmed by marijuana enforcement are benefitting the least from the legal marijuana marketplace.

“The MORE Act would address some of these negative impacts, by establishing an Opportunity Trust Fund within the Department of Treasury to fund programs within the Department of Justice and the Small Business Administration to empower communities of color and those adversely impacted by the War on Drugs. These programs would provide services to individuals, including job training, reentry services and substance use disorder services; provide funds for loans to assist small businesses that are owned and controlled by socially and economically disadvantaged individuals; and provide resources for programs that minimize barriers to marijuana licensing and employment for individuals adversely impacted by the War on Drugs.

“The collateral consequences of a conviction for marijuana possession—and even sometimes for a mere arrest—can be devastating.  For those saddled with a criminal conviction, it can be difficult or impossible to vote, to obtain educational loans, to get a job, to maintain a professional license, to secure housing, to receive government assistance, or even to adopt a child.

“These exclusions create an often-permanent second-class status for millions of Americans.  This is unacceptable and counterproductive, especially in light of the disproportionate impact that enforcement of marijuana laws has had on communities of color.  The MORE Act recognizes this injustice and addresses these harmful effects by expunging and sealing federal convictions and arrests for marijuana offenses.

“It is not surprising that over the past two decades, public support for legalizing marijuana has surged.  In the most recent Pew Research Center poll—which was released at the end of 2019—67 percent of Americans now back marijuana legalization, up from 62 percent in Pew’s 2018 poll.  And just this November, there were ballot measures pertaining to marijuana in several states; they were all approved by voters.  Indeed, the states have led the way—and continue to lead the way—on marijuana, but our federal laws have not kept pace with the obvious need for change.  We need to catch up because the public supports reform and because it is the right thing to do.

“In my view, applying criminal penalties, with their attendant collateral consequences for marijuana offenses is unjust and harmful to our society.  The MORE Act comprehensively addresses this injustice, and I urge all of my colleagues to support this bill today.”

CEI Leads Coalition Letter Supporting MORE Act Provision To De-Schedule Cannabis

Dear Speaker Pelosi, Leader Hoyer, Leader McCarthy, and Whip Scalise:

On behalf of the many of Americans whose views and values our organizations represent, we respectfully urge you to support efforts to remove cannabis from the Controlled Substances Act. While we oppose many aspects of the Marijuana Opportunity Reinvestment and Expungement (MORE) Act, we support its provision to de-schedule cannabis, which would restore the right to decide how to regulate the substance to the people and their state representatives. The undersigned organizations agree that this action is an important step toward undoing the harms caused by the misguided drug war and protecting our nation’s principle of federalism.

In the past election, voters in five states authorized medical cannabis use, recreational use, or both. In fact, every cannabis-legalization ballot measure throughout the country was approved by voters, bringing the total number of states that have legalized medical cannabis to 35 plus the District of Columbia and the number of states that have legalized recreational cannabis use for adults to 15, along with the District. In fact, all but two states have legalized or decriminalized cannabis in some form, properly adapting state policies to reflect the needs and opinions of their constituents. Yet, such responsive governance is hampered by the fact cannabis remains federally prohibited.

Congress has recognized the need to resolve this conflict for many years. Amendments to prevent federal interference in state cannabis regulation enjoy a long history of support among both House Republicans and Democrats. These measures can give states some flexibility to set policies in accordance with the will of their people. But the dual legal status of cannabis has created confusion and put the welfare of many citizens and businesses in jeopardy.

The federal prohibition has excluded small cannabis businesses from many of the financial and legal services or benefits afforded to other industries. The conflict also creates hazards for consumers of legal cannabis products, extending to issues of employment, housing, property rights, firearms purchasing, and civil asset forfeiture, among others. For example, patients who wish to participate in their state’s legal medical marijuana program must choose between their medicine and owning a gun, because the Gun Control Act of 1968 prohibits anyone who uses controlled substances from possessing guns or ammunition. Only Congress can resolve this conflict and there is strong, bipartisan public support for such action.

According to a November 2020 Gallup poll, 68 percent of all Americans believe the use of marijuana should be made legal, including 52 percent of Republican voters. There is even greater support for allowing states to make the decision without federal interference. A 2017 CBS News Poll found that 64 percent of Republican voters, 76 percent of Democrats, and 72 percent of independents opposed federal attempts to stop states from legalizing cannabis.

The undersigned organizations vary in our opinions on the specifics of cannabis legalization, but we are in strong accord when it comes to whether the federal or state governments should have the power to make such decisions. Our Constitution limits federal power and leaves most issues of law enforcement to the individual states for good reason. We are a nation of diverse backgrounds, opinions, and values. State authorities are best placed to understand the needs of their populace and must be free to decide how best to protect public health and safety and direct limited resources toward those priorities. What works for California may not be appropriate for Utah and vice versa. The federal government need not endorse one approach or another nor condone cannabis use; it needs only to respect the states’ authority to choose how best to regulate cannabis.

As a coalition of groups and individuals supporting free market solutions and the protection of essential constitutional principles, we strongly urge you to respect our nation’s federalist structure and support the MORE Act’s provision to de-schedule cannabis.

Sincerely,

Michelle Minton
Senior Fellow
Competitive Enterprise Institute

Andrew Langer
President, Institute for Liberty

David Williams
President
Taxpayers Protection Alliance

Arthur Rizer
Director of Criminal Justice & Civil Liberties Policy
R Street Institute

Meeting Announcement For H.R. 3884—Marijuana Opportunity Reinvestment And Expungement Act of 2019

 

DISTRICT OF COLUMBIA:  The Committee on Rules will meet on Wednesday, December 2, 2020 at 1:00 PM EST via Cisco Webex on the following measure:

  • H.R. 3884—Marijuana Opportunity Reinvestment and Expungement Act of 2019 [MORE Act of 2020]

**PLEASE NOTE:

  • This proceeding will be streamed live on rules.house.gov. Information will be provided separately to Members on how to join via theCisco Webex platform.
  • Members intending to testify during this meeting should notify the Rules Committee of their interest in order to receive instructions on how to participate.

Congressman Blumenauer Statement On Cannabis Reform Legislation Vote

The MORE Act would end the failed federal cannabis prohibition and ensure restorative justice

DISTRICT OF COLUMBIA: U.S. Rep Earl Blumenauer (D-OR), founder and co-chair of the Congressional Cannabis Caucus, released this statement today, following the announcement that the Marijuana Opportunity Reinvestment and Expungement (MORE) Act will be voted on by the U.S. House of Representatives next week: 

“I’ve been working on this issue longer than any politician in America and can confidently say that the MORE Act is the most comprehensive federal cannabis reform legislation in U.S. history. Our vote to pass it next week will come after people in five very different states reaffirmed the strong bipartisan support to reform the failed cannabis prohibition. National support for federal cannabis legalization is at an all-time high and almost 99% of Americans will soon live in states with some form of legal cannabis. Congress must capitalize on this momentum and do our part to end the failed policy of prohibition that has resulted in a long and shameful period of selective enforcement against communities of color.” 

The historic vote – which is expected next week – will mark the first time that the House or the Senate has ever voted as a full chamber on legislation to end the federal cannabis prohibition since it went into effect following the passage of the Controlled Substances Act of 1970.

In addition to decriminalizing marijuana at the federal level, the MORE Act would also expunge federal marijuana convictions and reinvest in communities most adversely impacted by the War on Drugs.     

Congressional Cannabis Caucus Co-Chairs Urge Colleagues to Pass Federal Cannabis Reform Following Sweeping Ballot Measure Victories

Cannabis reform was clear winner on election day

DISTRICT OF COLUMBIA:  U.S. Reps. Earl Blumenauer (D-OR) and Barbara Lee (D-CA), co-chairs of the Congressional Cannabis Caucus, sent a letter to their House colleagues urging strong support of comprehensive federal cannabis reform legislation that will be voted on this year.

The letter comes after resounding victories last week in Arizona, Montana, New Jersey, South Dakota and Mississippi, where voters approved a series of cannabis ballot measures. Cannabis will now be legalized for adult use in 15 states and medical use in 36 states.

“One of the biggest winners of the 2020 election was cannabis reform. Americans in five very different states voted overwhelmingly to liberalize their cannabis policies, and it is clearer than ever that the American people are demanding a change to outdated cannabis laws,” Blumenauer and Lee wrote. “There’s no question: cannabis prohibition will end soon. We should lead the way by passing H.R.3884 – Marijuana Opportunity Reinvestment and Expungement (MORE) Act.”

Yesterday, House leadership asserted that the MORE Act – landmark legislation to remove marijuana from the federal Controlled Substances Act and enact restorative justice for communities of color most impacted by the failed cannabis prohibition – would receive a vote on the House floor next month, which Blumenauer and Lee are urging their colleagues to support.

“The recent success of cannabis reform in states around the country should give us a new sense of urgency to ensure Congress catches up with the American people,” Blumenauer and Lee added. “This is a critical issue of racial justice, and the failed war on drugs has devastated communities of color, especially Black and brown communities. We can no longer ignore our duty to repair the damage that this harmful form of systemic racism has done.”

A PDF copy of the letter sent today by Blumenauer and Lee is available here.

Following is the full text:

Dear Colleague: 

One of the biggest winners of the 2020 election was cannabis reform. Americans in five very different states voted overwhelmingly to liberalize their cannabis policies and it is clearer than ever that the American people are demanding a change to outdated cannabis laws. There’s no question: cannabis prohibition will end soon. We should lead the way by passing H.R.3884 – Marijuana Opportunity Reinvestment and Expungement (MORE) Act. 

Last week’s results reaffirm the strong bipartisan support to reform our failed cannabis prohibition. Even in states where Republicans easily swept elections, like in Mississippi and South Dakota, cannabis-related ballot measures passed with strong support. The success in Arizona, Montana, Mississippi, New Jersey and South Dakota means that cannabis will be legal for adult use in 15 states and medical use in 36 states. More than 109 million people will live in states where cannabis is legal for adults to use, that is more than one in three Americans. In total, almost 99% of Americans will live in states with some form of legal cannabis. We cannot ignore the will of the people any longer.  

This comes as no surprise—national support for federal cannabis legalization is at an all-time high, and trends show that support will continue to grow. Polling from the Pew Research Center shows that 67% of registered voters think “the use of cannabis should be made legal,” and the Center for American Progress found that 73% support expunging the records of those previously convicted of cannabis-related offenses. This finding is confirmed by the fact that in the last three elections, 16 of the 18 pro-cannabis reform ballot initiatives were successful—even in places like Utah and Mississippi.

This past election further demonstrated that cannabis reform is popular, non-partisan, and the just thing to do as states have also made clear their commitment to restorative justice. Montana, which ranks first in the country for having the largest racial disparities for cannabis arrests will allow an individual currently serving a sentence for a prior low-level cannabis offense to apply for resentencing or an expungement of the conviction.

The recent success of cannabis reform in states around the country should give us a new sense of urgency to ensure Congress catches up with the American people. This is a critical issue of racial justice, and the failed war on drugs has devastated communities of color, especially Black and Brown communities. We can no longer ignore our duty to repair the damage that this harmful form of systemic racism has done.

The House was poised to vote on the MORE Act, the most comprehensive federal cannabis reform legislation we’ve ever seen, back in September. As the House kept our focus on providing struggling Americans with relief from COVID-19, we received commitment from our Caucus leadership that Congress would take steps to end the failed war on drugs by voting on the MORE Act before the year was over.  

We have an opportunity and duty to correct course now. As we head into the lame-duck session, we must remember the promise we made to the American people to pass the MORE Act.

Thank you for your urgency.

Virginia Congressman Riggleman Sends Letter To DEA In Support Of Hemp Industry

DISTRICT OF COLUMBIA:  Congressman Denver Riggleman, along with eight of his House colleagues, sent a letter to acting Drug Enforcement Agency (DEA) Administrator Timothy Shea to protect hemp producers and clarify hemp regulations due to discrepancies in the DEA Interim Final Rule (IFR).

The letter, led by Rep. David Joyce (R-OH-14), asks Administrator Shea to address the discrepancies between the 2018 Farm Bill and the DEA Interim Final Rule which was issued in August 2020. The IFR issued specific restrictions regarding hemp derived material that appears to contradict the legalization of hemp and hemp derivatives under the 2018 Farm Bill. According to the newly released IFR, provisions of the Farm Bill can result in criminal liability.

“The DEA must specify their requirements and streamline hemp directives by clarifying the legal means of processing hemp products,” said Congressman Riggleman. “The Farm Bill created new venues of business in this country, and we need to ensure that our hemp farmers have clear directives when it comes to their products.”

The 2018 Farm Bill is a critical piece of legislation that opened the door for hardworking hemp farmers by legalizing hemp and hemp derivatives so long as they contain less than 0.3% of THC on a dry weight basis. This bill has allowed states across America to start to build a new industry in hemp production, and expand their markets to CBD products and other related material. The DEA must revise the IFR to protect hemp farmers from overly harsh regulation and ensure that the hemp industry is safeguarded.

Background:

Congressman Riggleman has fought for hemp producers throughout his time in Congress. He is a lead supporter of the U.S. Domestic Hemp Production Program and has worked with USDA Secretary Sonny Perdue to expand economic opportunity for hemp farmers in the 5th District and beyond. Earlier this year he also introduced the Hemp Opportunity Zone Act which would designate certain low-income areas as “opportunity zones” and provide economic incentives to grow the hemp industry and encourage long-term investment in rural communities. The hemp industry has the potential to be a game changer for farmers in America and the 5th District can lead this effort.

Learn more about the industrial hemp industry from the USDA here. Learn about how a new hemp processing facility will strengthen the economy and bring more than 20 new jobs to South Boston, VA here.

 

Blumenauer Calls On Supreme Court To Review Historic Appeal Challenging The Constitutionality Of Federal Criminalization Of Cannabis

DISTRICT OF COLUMBIA:  U.S. Rep. Earl Blumenauer (D-OR), founder and co-chair of the Congressional Cannabis Caucus, called upon the U.S. Supreme Court to review and proceed with hearing Washington v. Barr, the most significant and potentially consequential cannabis-related lawsuit ever to be filed.

The Court will consider the plaintiffs’ appeal at a conference on Friday, October 9, and if the Court accepts the appeal for consideration, it could pave the way to federal legalization of cannabis for the first time since 1937, providing relief to millions of Americans who treat with medical marijuana to maintain their health and lives. If the Court were to decline to hear the appeal, the case would be over for good, resigning another generation of medical marijuana patients and the state-legal cannabis industry – which has invested billions in the state-legal market – to further legal uncertainty.

“The fact that nearly 94 percent of Americans support legalizing medical cannabis and yet it remains illegal at the federal level is a national disgrace,” said Blumenauer. “Furthermore, the laws and subsequent court decisions on cannabis are a mangled patchwork of contradictions. This case is an important opportunity to fix our failed national cannabis laws.”

In July 2020, the plaintiffs in Washington v. Barr filed their appeal with the U.S. Supreme Court, challenging the constitutionality of the federal criminalization of medical marijuana. The case was filed on behalf of five plaintiffs, including former NFL player Marvin Washington, Iraq War Veteran Jose Belen, 15-year-old Alexis Bortell, nine-year-old Jagger Cotte and the Cannabis Cultural Association.

As acknowledged by the District Court in this case, Alexis, Jagger and Specialist Belen are patients whose lives have been saved by medical cannabis. As reflected in the Complaint, Marvin Washington is a cannabis entrepreneur whose business would otherwise be eligible for federal funding through the Minority Business Enterprise program, but for his participation in the cannabis industry. The Cannabis Cultural Association seeks economic parity and social justice for persons of color who have been unfairly singled out for prosecution under the Controlled Substances Act and unjustly excluded economically from the state-legal cannabis industry.

Blumenauer along with seven federal lawmakers submitted an amicus brief in support of the plaintiff’s appeal. The case also has amicus brief support from 19 advocacy groups, including the National Organization for the Reform of Marijuana Laws (NORML), the International Cannabis Bar Association, National Cannabis Industry Association (NCIA), Last Prisoner Project, Minority Cannabis Business Association, and Americans For Safe Access.

Despite its legalization by 38 U.S. states and territories, cannabis is illegal at the federal level, creating insurmountable problems for patients around the country. Patients have lost their jobs, been expelled from colleges, and lost their professional licenses, even if state-legal jurisdictions, due to cannabis stigmatization wrought by federal prohibition.

While cannabis is also on the ballot in five states that will be voting on some form of cannabis legalization in November, adoption of legalization electorally on the state level will not solve the problems associated with federal prohibition. Rather, it would merely reinforce the absurdity of marijuana’s classification under Schedule I.

To read the full amicus brief filed on behalf of Blumenauer and his Congressional colleagues, click here.

Steny H. Hoyer, House Majority Leader ‘Dear Colleague’ Update On September Floor Schedule

 Confirms Legalization On Docket For Third Week Of September

August 31, 2020

Dear Colleague:

On September 8, the House will return for its Committee Work Period, to be followed on September 14 with a busy legislative work period.  I want to thank all of you for your efforts during the August District Work Period, which involved engaging closely with constituents, community leaders, and civic organizations working hard to address the COVID-19 pandemic and other pressing national challenges.  It also involved a brief return last weekend to Washington to pass the Delivering for America Act, which would end President Trump’s sabotage of the U.S. Postal Service, a vital service to American communities and to our democracy.

While we have all been waiting for the Senate to take action on the Heroes Act, it appears that the Republicans who control that chamber are not in a hurry to do their jobs and pass an emergency assistance package to help American workers and their families get through this economic and public health crisis.  If that changes, the House will return immediately to ensure that emergency assistance is delayed no further.  I will, as stated previously, provide twenty-four hours’ notice before any Floor action. The American people need this assistance, and this will continue to be our priority in September.

Looking ahead to the week of September 14, the House will consider the following pieces of legislation on the Floor.  First, we will take up a number of bills from the Education and Labor Committee, including: Rep. Fudge’s Strength in Diversity Act, Chairman Scott’s Equity and Inclusion in Education Act, and Chairman Nadler’s Pregnant Workers’ Fairness Act.  All of these would further Democrats’ agenda of ensuring that American workers can succeed in our economy regardless of their race, sex, or background.  They are based on the premise that everyone ought to have a fair and equal chance to make it in America.  In addition, the House will also consider a bipartisan resolution offered by Rep. Meng condemning all forms of anti-Asian bias and bigotry related to the COVID-19 pandemic.

The following week, the House will take up Chairman Nadler’s MORE Act to help restore justice to millions by decriminalizing marijuana and expunging records of nonviolent federal cannabis convictions.  Additionally, the House will consider a package of legislation reported out of the Energy and Commerce Committee and the Science, Space, and Technology Committee to invest in energy innovation and clean energy development.  These bills have broad support from across the aisle and from business and environmental groups, who together recognize that Congress must lead in promoting a cleaner, more sustainable energy future that drives innovation and helps us create good jobs for American workers.  The House may also take up legislation to reauthorize our intelligence agencies and ensure that they can do their jobs free from political interference and with the latest tools to protect against foreign threats while safeguarding Americans’ civil rights.

By September 30th, Congress must complete our work on appropriations and other expiring items, such as flood insurance and surface transportation.  In July, the Democratic-led House passed legislation to fund nearly all of the government, yet to date the Senate has not held even a single markup of an appropriations bill.  At this rate, it is likely that we will have to pass a continuing resolution to keep government open past the end of this fiscal year.  While that is not ideal, the House will do its job to avert a shutdown that would only further damage our economy.

Throughout September, the Democratic-led House will show the American people what responsible governance looks like, doing its job to legislate For the People.  I thank you in advance for your hard work and contributions, and I look forward to seeing you either virtually or in person when the House returns to session.

Sincerely,

STENY H. HOYER
House Majority Leader